StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Highlights  
 
  Updates  
 
 
 
Altimmune
12.09
-0.08%
 

ALT

 

Altimmune

$ 12.09

 
-$0.01 | -0.08%
 
 
Open
$ 12.16
 
 
MKT CAP
$ 649.58M
 
High
$ 12.68
 
 
VOL
$ 0.00K
 
Low
$ 11.92
 
 
AVG VOL
$ 5.92M
 
 
 

ALT Stock Analysis

  Login to display Altimmune (ALT) recommendation from the last 90 days from financial news and social media.
 
 

ALT Total Score

 
 

Strengths

ALT Rewards

 Earnings are forecast to grow

ALT Rewards

 Investors confidence is positive

 

Risk Analysis

ALT Risk Analysis

 Insider selling during the past 3 months

 
 

Chart

 
 

9.25

5.51

2.33

11.05

 
 
1month
3month
6month
1year
 

ALT Risk Level

This Indicator assigning ALT risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
ALT Risk Level
LOW
HIGH

Risk Volatility

 

ALT has Low Risk Level

Click here to check what is your level of risk

 

ALT Analysts Opinion

ALT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

4.00
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

3.29
 

ALT Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

2.40
 

ALT Activity Sentiment

 Investors confidence is positive

ALT Activity Sentiment

 Insider selling during the past 3 months

 

Future

×
 

Future

4.00
 

ALT Future Sentiment

 Earnings are forecast to grow

 
 

ALT Analysts Opinion

ALT Analysts opinion is negative and it remained unchanged from the past 3 months

 

ALT Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
56%
Buy
Opinion
Trend
Score
Potential
Score
 
 
NA
57%
100%
 
On Track
On Track
On Track
 

ALT Street Opinion 

ALT Street view is bullish and have positive views on the near-term outlook

 

ALT Performance Sentiment

Sentiments overview associated with ALT events and the stock performance.
 
56%
38%
Positive
Negative
9 out of 16
events present
6 out of 16
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Highlights
Last Modify
Price
% Change

 
Insider Selling
2 Weeks Ago
9.01
+6.50%
 
 
 
joker
 
 
 
StocksRunner

Explore our ALT Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our ALT Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

ALT Rewards

 Earnings are forecast to grow

ALT Rewards

 Investors confidence is positive

 

Risk Analysis

 

ALT Risk Analysis

 Insider selling during the past 3 months

 
 
 

ALT Risk Level

 
 
 

The Indicator assigning ALT risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
ALT Risk Level
LOW
HIGH

Risk Volatility

 

ALT has Low Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

ALT

 

Altimmune

$ 12.09

 
-$0.01 | -0.08%
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 12.16
 
 
MKT CAP
$ 649.58M
 
High
$ 12.68
 
 
VOL
$ 0.00K
 
Low
$ 11.92
 
 
AVG VOL
$ 5.92M
 
 
 

ALT Analysis

  Sign in to view Altimmune (ALT) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

9.25

5.51

2.33

11.05

 
 
1month
3month
6month
1year
 

ALT Analysts Opinion

ALT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

4.00
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

3.29
 

ALT Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

2.40
 

ALT Activity Sentiment

 Investors confidence is positive

ALT Activity Sentiment

 Insider selling during the past 3 months

 

Future

×
 

Future

4.00
 

ALT Future Sentiment

 Earnings are forecast to grow

 
 

ALT Analysts Opinion

ALT Analysts opinion is negative and it remained unchanged from the past 3 months

 

ALT Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
56%
Buy
Opinion
Trend
Score
Potential
Score
 
 
NA
57%
100%
 
On Track
On Track
On Track
 

ALT Street Opinion 

ALT Street view is bullish and have positive views on the near-term outlook

 
ALT Performance Sentiment
Sentiments overview associated with ALT events and the stock performance.
 
56%
38%
Positive
Negative
9 out of 16
events present
6 out of 16
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Highlights
Last Modify
Price
% Change

 
Insider Selling
2 Weeks Ago
9.01
+6.50%
 
 
ALT Latest News Feed

Heres How Much $100 Invested In Altimmune 5 Years Ago Would Be Worth Today. Altimmune (NASDAQ:) has outperformed the market over the past 5 years by 24.97% on an annualized basis producing an average annual return of 37.62%. Currently Altimmune has a mark

Wed Feb 28, 2024

Activity

Weight-Loss Tizzy: Why One Stock Surged 27% And Others Tumbled. Biotech stocks Akero Therapeutics (AKRO) and Altimmune (ALT) diverged Monday as Wall Street debated the outcome of a weight-loss drug study from Zealand Pharma and Boehringer Ingelheim in pat

Mon Feb 26, 2024

Momentum
Momentum

Monday Sector Leaders: Biotechnology Education & Training Services. In trading on Monday biotechnology shares were relative leaders up on the day by about 2.9%. Leading the group were shares of Krystal Biotech up about 35.1% and shares of Alt

Mon Feb 26, 2024

Momentum
Potential

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune Inc. - ALT. NEW YORK Feb. 24 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Altimmune Inc. (Altimmune or the Company) (NASD

Sat Feb 24, 2024

Activity

Guru Fundamental Report for ALT - Benjamin Graham. Below is Valideas guru fundamental report for ALTIMMUNE INC (ALT). Of the 22 guru strategies we follow ALT rates highest using our Value Investor model based on the published strategy of Benjam

Thu Feb 22, 2024

Potential

ROSEN LEADING INVESTOR COUNSEL Encourages Altimmune Inc. Investors to Inquire About Securities Class Action Investigation - ALT. NEW YORK Feb. 16 2024 /PRNewswire/ -- WHY: Rosen Law Firm a global investor rights law firm announces an investigation of pote

Fri Feb 16, 2024

Activity

(ALT) - Analyzing Altimmunes Short Interest. ) short percent of float has fallen 6.1% since its last report. The company recently reported that it has Short interest is the number of shares that have been sold short but have not yet been covered or clos

Wed Feb 14, 2024

Activity
Momentum

Altimmune stock climbs 9% amid Jefferies note on recent sell-off.

Wed Feb 14, 2024

Momentum

Altimmune shares slide after Kerrisdale Capital takes short position. Shares of obesity drug developer Altimmune fell more than 12% to $9.09 on Tuesday after Kerrisdale Capital took a short position on the companys stock.

Tue Feb 13, 2024

Momentum

alt factor-based stock analysis - benjamin graham. below is valideas guru fundamental report for altimmune inc (alt). of the 22 guru strategies we follow alt rates highest using our value investor model based on the published strategy of benjam

Wed Jan 17, 2024

Potential

thoroughly derisked altimmune is now a great buy.

Wed Jan 10, 2024

Potential

 
 
 
 
 

Score Tracker

 
 
 
Based on 16 events in the last 90 days from financial news and social media. Last updated Mar 1, 2024 23:12 Wall St. time
 
 

ALT Total Score

 
 
 
 
 
 
 
StocksRunner

Discover ALT Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of ALT. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our ALT Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ALT Stock trends

ALT Stock performance

ALT Stock analysis

ALT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker